GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HSF1 | hg38_v1_chr8_+_144291581_144291617 | 0.00 | 9.6e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_83109843 Show fit | 13.28 |
ENST00000411416.6
|
placenta associated 8 |
|
chr1_+_110873135 Show fit | 11.69 |
ENST00000271324.6
|
CD53 molecule |
|
chr1_-_153390976 Show fit | 10.91 |
ENST00000368732.5
ENST00000368733.4 |
S100 calcium binding protein A8 |
|
chr12_-_52517929 Show fit | 10.64 |
ENST00000548409.5
|
keratin 5 |
|
chr2_-_89213917 Show fit | 10.06 |
ENST00000498435.1
|
immunoglobulin kappa variable 1-27 |
|
chr11_-_102452758 Show fit | 8.97 |
ENST00000398136.7
ENST00000361236.7 |
transmembrane protein 123 |
|
chr6_+_32637419 Show fit | 8.92 |
ENST00000374949.2
|
major histocompatibility complex, class II, DQ alpha 1 |
|
chr19_-_2051224 Show fit | 8.27 |
ENST00000309340.11
ENST00000589534.2 ENST00000250896.9 ENST00000589509.5 |
MAPK interacting serine/threonine kinase 2 |
|
chr17_-_41505597 Show fit | 8.15 |
ENST00000336861.7
ENST00000246635.8 ENST00000587544.5 ENST00000587435.1 |
keratin 13 |
|
chr5_+_119354771 Show fit | 7.70 |
ENST00000503646.1
|
TNF alpha induced protein 8 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 24.7 | GO:0002250 | adaptive immune response(GO:0002250) |
0.2 | 20.5 | GO:0031295 | T cell costimulation(GO:0031295) |
0.6 | 14.9 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.7 | 12.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 12.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.4 | 11.7 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 11.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 11.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.0 | 10.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 9.0 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 23.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 22.7 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.2 | 19.3 | GO:0035579 | specific granule membrane(GO:0035579) |
0.4 | 18.6 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 17.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 17.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 17.3 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 13.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 12.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.3 | 10.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 17.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 17.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.1 | 16.0 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 15.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 14.9 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 12.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
3.6 | 10.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 10.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 10.1 | GO:0097110 | scaffold protein binding(GO:0097110) |
3.3 | 10.0 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 20.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 14.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 10.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 8.7 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 8.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 8.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 7.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 7.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 7.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 6.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 25.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 19.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 13.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 10.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 9.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 8.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 8.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 7.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 7.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 7.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |